Survival trends for patients diagnosed with cutaneous malignant melanoma in the Nordic countries 1990-2016 : The NORDCAN survival studies

Background: The survival in patients diagnosed with cutaneous malignant melanoma (CMM) has improved in the Nordic countries in the last decades. It is of interest to know if these improvements are observed in all ages and for both women and men. Methods: Patients diagnosed with CMM in the Nordic cou...

Full description

Bibliographic Details
Published in:European Journal of Cancer
Main Authors: Lundberg, Frida E., Birgisson, Helgi, Engholm, Gerda, Ólafsdóttir, Elínborg J., Mørch, Lina Steinrud, Johannesen, Tom Børge, Pettersson, David, Lambe, Mats, Seppä, Karri, Lambert, Paul C., Johansson, Anna L.V., Hölmich, Lisbet Rosenkrantz, Andersson, Therese M.L.
Other Authors: Tampere University, Health Sciences
Format: Article in Journal/Newspaper
Language:English
Published: 2024
Subjects:
Online Access:https://trepo.tuni.fi/handle/10024/155797
https://doi.org/10.1016/j.ejca.2024.113980
id ftunivtampere:oai:trepo.tuni.fi:10024/155797
record_format openpolar
spelling ftunivtampere:oai:trepo.tuni.fi:10024/155797 2024-04-28T08:26:04+00:00 Survival trends for patients diagnosed with cutaneous malignant melanoma in the Nordic countries 1990-2016 : The NORDCAN survival studies Lundberg, Frida E. Birgisson, Helgi Engholm, Gerda Ólafsdóttir, Elínborg J. Mørch, Lina Steinrud Johannesen, Tom Børge Pettersson, David Lambe, Mats Seppä, Karri Lambert, Paul C. Johansson, Anna L.V. Hölmich, Lisbet Rosenkrantz Andersson, Therese M.L. Tampere University Health Sciences 2024-05 1876467 fulltext https://trepo.tuni.fi/handle/10024/155797 https://doi.org/10.1016/j.ejca.2024.113980 en eng 113980 202 0959-8049 https://trepo.tuni.fi/handle/10024/155797 URN:NBN:fi:tuni-202403263100 doi:10.1016/j.ejca.2024.113980 cc by 4.0 openAccess 3142 Public health care science environmental and occupational health article 2024 ftunivtampere https://doi.org/10.1016/j.ejca.2024.113980 2024-04-03T14:29:48Z Background: The survival in patients diagnosed with cutaneous malignant melanoma (CMM) has improved in the Nordic countries in the last decades. It is of interest to know if these improvements are observed in all ages and for both women and men. Methods: Patients diagnosed with CMM in the Nordic countries in 1990–2016 were identified in the NORDCAN database. Flexible parametric relative survival models were fitted, except for Iceland where a non-parametric Pohar-Perme approach was used. A range of survival metrics were estimated by sex, both age-standardised and age-specific. Results: The 5-year relative survival improved in all countries, in both women and men and across age. While the improvement was more pronounced in men, women still had a higher survival at the end of the study period. The survival was generally high, with age-standardised estimates of 5-year relative survival towards the end of the study period ranging from 85% in Icelandic men to 95% in Danish women. The age-standardised and reference-adjusted 5-year crude probability of death due to CMM ranged from 5% in Danish and Swedish women to 13% in Icelandic men. Conclusion: Although survival following CMM was relatively high in the Nordic countries in 1990, continued improvements in survival were observed throughout the study period in both women and men and across age. Peer reviewed Article in Journal/Newspaper Iceland Tampere University: Trepo European Journal of Cancer 202 113980
institution Open Polar
collection Tampere University: Trepo
op_collection_id ftunivtampere
language English
topic 3142 Public health care science
environmental and occupational health
spellingShingle 3142 Public health care science
environmental and occupational health
Lundberg, Frida E.
Birgisson, Helgi
Engholm, Gerda
Ólafsdóttir, Elínborg J.
Mørch, Lina Steinrud
Johannesen, Tom Børge
Pettersson, David
Lambe, Mats
Seppä, Karri
Lambert, Paul C.
Johansson, Anna L.V.
Hölmich, Lisbet Rosenkrantz
Andersson, Therese M.L.
Survival trends for patients diagnosed with cutaneous malignant melanoma in the Nordic countries 1990-2016 : The NORDCAN survival studies
topic_facet 3142 Public health care science
environmental and occupational health
description Background: The survival in patients diagnosed with cutaneous malignant melanoma (CMM) has improved in the Nordic countries in the last decades. It is of interest to know if these improvements are observed in all ages and for both women and men. Methods: Patients diagnosed with CMM in the Nordic countries in 1990–2016 were identified in the NORDCAN database. Flexible parametric relative survival models were fitted, except for Iceland where a non-parametric Pohar-Perme approach was used. A range of survival metrics were estimated by sex, both age-standardised and age-specific. Results: The 5-year relative survival improved in all countries, in both women and men and across age. While the improvement was more pronounced in men, women still had a higher survival at the end of the study period. The survival was generally high, with age-standardised estimates of 5-year relative survival towards the end of the study period ranging from 85% in Icelandic men to 95% in Danish women. The age-standardised and reference-adjusted 5-year crude probability of death due to CMM ranged from 5% in Danish and Swedish women to 13% in Icelandic men. Conclusion: Although survival following CMM was relatively high in the Nordic countries in 1990, continued improvements in survival were observed throughout the study period in both women and men and across age. Peer reviewed
author2 Tampere University
Health Sciences
format Article in Journal/Newspaper
author Lundberg, Frida E.
Birgisson, Helgi
Engholm, Gerda
Ólafsdóttir, Elínborg J.
Mørch, Lina Steinrud
Johannesen, Tom Børge
Pettersson, David
Lambe, Mats
Seppä, Karri
Lambert, Paul C.
Johansson, Anna L.V.
Hölmich, Lisbet Rosenkrantz
Andersson, Therese M.L.
author_facet Lundberg, Frida E.
Birgisson, Helgi
Engholm, Gerda
Ólafsdóttir, Elínborg J.
Mørch, Lina Steinrud
Johannesen, Tom Børge
Pettersson, David
Lambe, Mats
Seppä, Karri
Lambert, Paul C.
Johansson, Anna L.V.
Hölmich, Lisbet Rosenkrantz
Andersson, Therese M.L.
author_sort Lundberg, Frida E.
title Survival trends for patients diagnosed with cutaneous malignant melanoma in the Nordic countries 1990-2016 : The NORDCAN survival studies
title_short Survival trends for patients diagnosed with cutaneous malignant melanoma in the Nordic countries 1990-2016 : The NORDCAN survival studies
title_full Survival trends for patients diagnosed with cutaneous malignant melanoma in the Nordic countries 1990-2016 : The NORDCAN survival studies
title_fullStr Survival trends for patients diagnosed with cutaneous malignant melanoma in the Nordic countries 1990-2016 : The NORDCAN survival studies
title_full_unstemmed Survival trends for patients diagnosed with cutaneous malignant melanoma in the Nordic countries 1990-2016 : The NORDCAN survival studies
title_sort survival trends for patients diagnosed with cutaneous malignant melanoma in the nordic countries 1990-2016 : the nordcan survival studies
publishDate 2024
url https://trepo.tuni.fi/handle/10024/155797
https://doi.org/10.1016/j.ejca.2024.113980
genre Iceland
genre_facet Iceland
op_relation 113980
202
0959-8049
https://trepo.tuni.fi/handle/10024/155797
URN:NBN:fi:tuni-202403263100
doi:10.1016/j.ejca.2024.113980
op_rights cc by 4.0
openAccess
op_doi https://doi.org/10.1016/j.ejca.2024.113980
container_title European Journal of Cancer
container_volume 202
container_start_page 113980
_version_ 1797585607173603328